Search by Drug Name or NDC
NDC 50201-4213-06 Top Value Effervescent Pain Relief 1000; 325; 1916 mg/1; mg/1; mg/1 Details
Top Value Effervescent Pain Relief 1000; 325; 1916 mg/1; mg/1; mg/1
Top Value Effervescent Pain Relief is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Tower Laboratories Ltd. The primary component is ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE.
Product Information
| NDC | 50201-4213 |
|---|---|
| Product ID | 50201-4213_f0465d32-30b7-0ac9-e053-2995a90a26b9 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Top Value Effervescent Pain Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Aspirin, Citric Acid, Sodium Bicarobonate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Active Ingredient Strength | 1000; 325; 1916 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE |
| Labeler Name | Tower Laboratories Ltd |
| Pharmaceutical Class | Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Ac |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part343 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50201-4213-06 (50201421306)
| NDC Package Code | 50201-4213-6 |
|---|---|
| Billing NDC | 50201421306 |
| Package | 18 POUCH in 1 CARTON (50201-4213-6) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| Marketing Start Date | 2006-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |